Apidra FDA Approval History
FDA Approved: Yes (First approved April 16, 2004)
Brand name: Apidra
Generic name: insulin glulisine
Dosage form: Injection
Company: Aventis Pharmaceuticals Inc.
Treatment for: Diabetes, Type 1, Diabetes, Type 2
Apidra (insulin glulisine) is a rapid-acting recombinant DNA human insulin analogue used for the control of hyperglycemia in patients with diabetes mellitus.
Development timeline for Apidra
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.